Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Fosbrink

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Immunologic Research|December 14, 2004
The role of c5b-9 terminal complement complex in activation of the cell cycle and transcriptionMatthew Fosbrink, Florin Niculescu, Horea Rus
The Journal of Biological Chemistry|October 12, 2007
Live-cell molecular analysis of Akt activation reveals roles for activation loop phosphorylationBharath Ananthanarayanan, Matthew Fosbrink, Meghdad Rahdar, et al.
Journal of the Peripheral Nervous System : JPNS|March 8, 2006
JNK1 activation mediates C5b-9-induced P0 mRNA instability and P0 gene expression in Schwann cellsStefan David, Sorana Hila, Matthew Fosbrink, et al.
The Journal of Biological Chemistry|May 4, 2006
C5b-9-induced endothelial cell proliferation and migration are dependent on Akt inactivation of forkhead transcription factor FOXO1Matthew Fosbrink, Florin Niculescu, Violeta Rus, et al.
The Journal of Biological Chemistry|January 13, 2006
Cell cycle-dependent phosphorylation of the RUNX2 transcription factor by cdc2 regulates endothelial cell proliferationMeng Qiao, Paul Shapiro, Matthew Fosbrink, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 10, 2010
Visualization of JNK activity dynamics with a genetically encoded fluorescent biosensorMatthew Fosbrink, Nwe-Nwe Aye-Han, Raymond Cheong, et al.
The Journal of Biological Chemistry|November 1, 2001
RGC-32 increases p34CDC2 kinase activity and entry of aortic smooth muscle cells into S-phaseTudor Badea, Florin Niculescu, Lucian Soane, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2006
C5b-9 terminal complex protects oligodendrocytes from apoptotic cell death by inhibiting caspase-8 processing and up-regulating FLIPCornelia Cudrici, Florin Niculescu, Timothy Jensen, et al.
Experimental and Molecular Pathology|February 17, 2005
Overexpression of RGC-32 in colon cancer and other tumorsMatthew Fosbrink, Cornelia Cudrici, Florin Niculescu, et al.
Archivum Immunologiae Et Therapiae Experimentalis|April 1, 2008
Role of response gene to complement 32 in diseasesSonia I Vlaicu, Cornelia Cudrici, Takahiro Ito, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Immunologic Research|December 14, 2004
The role of c5b-9 terminal complement complex in activation of the cell cycle and transcriptionMatthew Fosbrink, Florin Niculescu, Horea Rus
The Journal of Biological Chemistry|October 12, 2007
Live-cell molecular analysis of Akt activation reveals roles for activation loop phosphorylationBharath Ananthanarayanan, Matthew Fosbrink, Meghdad Rahdar, et al.
Journal of the Peripheral Nervous System : JPNS|March 8, 2006
JNK1 activation mediates C5b-9-induced P0 mRNA instability and P0 gene expression in Schwann cellsStefan David, Sorana Hila, Matthew Fosbrink, et al.
The Journal of Biological Chemistry|May 4, 2006
C5b-9-induced endothelial cell proliferation and migration are dependent on Akt inactivation of forkhead transcription factor FOXO1Matthew Fosbrink, Florin Niculescu, Violeta Rus, et al.
The Journal of Biological Chemistry|January 13, 2006
Cell cycle-dependent phosphorylation of the RUNX2 transcription factor by cdc2 regulates endothelial cell proliferationMeng Qiao, Paul Shapiro, Matthew Fosbrink, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 10, 2010
Visualization of JNK activity dynamics with a genetically encoded fluorescent biosensorMatthew Fosbrink, Nwe-Nwe Aye-Han, Raymond Cheong, et al.
The Journal of Biological Chemistry|November 1, 2001
RGC-32 increases p34CDC2 kinase activity and entry of aortic smooth muscle cells into S-phaseTudor Badea, Florin Niculescu, Lucian Soane, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2006
C5b-9 terminal complex protects oligodendrocytes from apoptotic cell death by inhibiting caspase-8 processing and up-regulating FLIPCornelia Cudrici, Florin Niculescu, Timothy Jensen, et al.
Experimental and Molecular Pathology|February 17, 2005
Overexpression of RGC-32 in colon cancer and other tumorsMatthew Fosbrink, Cornelia Cudrici, Florin Niculescu, et al.
Archivum Immunologiae Et Therapiae Experimentalis|April 1, 2008
Role of response gene to complement 32 in diseasesSonia I Vlaicu, Cornelia Cudrici, Takahiro Ito, et al.
Pageof 2